Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating nociceptin levels during the cluster headache period.

C Ertsey1, M Hantos, G Bozsik

  • 1Department of Neurology, Semmelweis University, Budapest, Hungary. csaba@neur.sote.hu

Cephalalgia : an International Journal of Headache
|March 20, 2004
PubMed
Summary

Cluster headache patients have lower nociceptin levels during attacks, suggesting a link to trigeminal nerve dysfunction. Levels normalize after the cluster period, indicating a potential role in headache regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of K117 and K127, two novel antidote candidates to treat Tabun poisoning.

Chemico-biological interactions·2019
Same author

Molecular cloning, mRNA expression and biological activity of the pheromone biosynthesis activating neuropeptide (PBAN) from the European corn borer, Ostrinia nubilalis.

Insect molecular biology·2017
Same author

Mini review on blood-brain barrier penetration of pyridinium aldoximes.

Journal of applied toxicology : JAT·2014
Same author

Metabolism of selegiline [(-)-deprenyl)].

Current medicinal chemistry·2013
Same author

Medicinal chemistry of antimigraine drugs.

Current medicinal chemistry·2013
Same author

Study on medicinal chemistry of K203 in wistar rats and beagle dogs.

Current medicinal chemistry·2013

Area of Science:

  • Neuroscience
  • Pain Research
  • Endocrinology

Background:

  • The trigeminal system and its neuropeptides are implicated in cluster headache pathophysiology.
  • Nociceptin, an opioid neuropeptide, interacts with the OP-4 receptor and influences pain pathways.
  • Nociceptin and its receptor are found in trigeminal ganglion cells, co-localizing with calcitonin gene-related peptide.

Purpose of the Study:

  • To investigate the role of nociceptin in cluster headache by measuring its circulating levels.
  • To compare nociceptin levels in cluster headache patients during and after the cluster period with healthy controls.

Main Methods:

  • Radioimmunoassay was used to quantify serum nociceptin levels.
  • 14 cluster headache patients were studied during their cluster period and after remission.

Related Experiment Videos

  • Patient data were compared to age- and sex-matched control groups.

    • Main Results:

    • Significantly lower circulating nociceptin levels were observed in cluster headache patients during the cluster period compared to controls.
    • Nociceptin levels normalized and were not statistically different from controls after the cluster period terminated.
    • No correlation was found between nociceptin levels and patient age, disease duration, or episode length.

    Conclusions:

    • Reduced nociceptin levels during the cluster period may impair trigeminal activity regulation.
    • This dysregulation could contribute to insufficient protection against cluster headache attacks.
    • Nociceptin modulation might represent a future therapeutic target for cluster headache.